Surgical sealants, glues, hemostats, anti-adhesion and other wound products, market forecast

PRLog (Press Release) - Jan 25, 2012 - The demand for products in the management of medical/surgical wounds -- closure, securement, sealing, hemostasis and anti-adhesion -- has become characterized by clinicians and healthcare systems seeking to efficiently and rapidly manage wounds such that a minimum of resources are needed and few if any complications arise that might impede successful wound healing. Advanced sealing, hemostasis or other products that can be used alone or adjunctively with traditional wound management products (sutures, staples, dressings) have already demonstrated (over the past 10+ years) the ability to facilitate reaching desired outcomes.  Nonetheless, despite relatively low barriers to market entry, companies’ market success (or just survival) is dictated by companies’ abilities to gain the clinical and healthcare system acceptance necessary to establish long(er) terms presence in the wound closure and securement market.  The current and forecast market for wound securement products is detailed in the MedMarket Diligence 2012 report, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017.”

“Based simply on the number of active manufacturers and developers, there is clearly no question that market opportunity is sufficient to attract participants even with only marginally different wound closure and securement products --- but succeeding in this market and maintaining any kind of long-term presence requires that manufacturers stay closely aligned with the needs of clinicians and tuned in to the challenging demands of healthcare systems and third party payers,” says Patrick Driscoll, President of MedMarket Diligence and publisher of the 2012 report on surgical sealants, glues and related products (described at http://www.mediligence.com/rpt/rpt-s190.htm).

According to the MedMarket Diligence report, there are over a hundred companies active worldwide in the development and marketing of products for advanced wound closure and securement, a clinical field addressed by fibrin sealants and gluse, cyanoacrylate (and other) high-strength glues, hemostasis products, and anti-adhesion, as well as traditional wound closure products such as surgical sutures, staples and clips.  

The market potential for the future utilization of these products is linked to the forces underlying a large number of different medical and surgical procedures.  Use of these technologies in a variety of roles (hemostasis, closure, sealing, anti-adhesion) is increasingly becoming routine in surgical and non-surgical clinical practices. Demographic forces are also driving potential caseloads upward, further expanding the market potential. Changing regulatory demands will continue to influence the markets for these products, although this influence may drive demand up or cause a decrease in demand, depending upon the specialty involved and/or the specific procedure employed.

Overall, product adoption and demographic trends are combining with new product introductions to accelerate market growth. There continues to be a significant and increasing potential for these products: they could find utilization in well over 100 million procedures globally. Growth in use of surgical sealants, glues, wound closure and anti- adhesion products is predicted to exceed double-digit annual rates for new products, and for established products in geographic markets that have yet to be fully developed.

The MedMarket Diligence Report #S190 (see http://www.mediligence.com/rpt/rpt-s190.htm for complete details) assesses the worldwide market for the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, including tapes, sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and medical adhesives and anti-adhesion products. The report details the current clinical and technology developments, with data on products in development (detailing market status) and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. The report provides full year actual data from 2011 and the worldwide forecast to 2017 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the forecast period. The report provides specific forecasts and shares of the worldwide market by segment for Americas (detail for U.S., Rest of North America and Latin America), Europe (detail for United Kingdom, German, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail for Japan, Korea, Rest of Asia/Pacific) and Rest of World.